Cassava Sciences
SAVA
$21.08
Share price
5.32%
Change (1 day)
-14.64%
Change (1 year)
Categories
Revenue for Cassava Sciences (SAVA)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cassava Sciences from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | -100% |
| 2013 | $41.11 M | 277.58% |
| 2012 | $10.89 M | -5.17% |
| 2011 | $11.48 M | -31.68% |
| 2010 | $16.8 M | -18.26% |
| 2009 | $20.56 M | -67.73% |
| 2008 | $63.72 M | -3.43% |
| 2007 | $65.98 M | 22.38% |
| 2006 | $53.91 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |